Frankfurt - Delayed Quote EUR

Euroapi S.A. (940.F)

Compare
3.1480
+0.0660
+(2.14%)
As of 8:18:02 PM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
971,300.0000
1,018,900.0000
980,900.0000
892,800.0000
944,600.0000
Cost of Revenue
805,800.0000
854,300.0000
804,000.0000
783,700.0000
854,100.0000
Gross Profit
165,600.0000
164,600.0000
176,900.0000
109,100.0000
90,400.0000
Operating Expense
162,100.0000
160,900.0000
149,800.0000
107,600.0000
98,800.0000
Operating Income
3,500.0000
3,700.0000
27,100.0000
1,500.0000
-8,400.0000
Net Non Operating Interest Income Expense
-11,800.0000
-8,400.0000
4,000.0000
-1,900.0000
-900.0000
Pretax Income
-296,900.0000
-242,800.0000
3,100.0000
-14,600.0000
-11,800.0000
Tax Provision
-9,600.0000
-53,000.0000
18,200.0000
-6,500.0000
-5,500.0000
Net Income Common Stockholders
-287,300.0000
-189,700.0000
-15,000.0000
-8,100.0000
-6,300.0000
Diluted NI Available to Com Stockholders
-287,300.0000
-189,700.0000
-15,000.0000
-8,100.0000
-6,300.0000
Basic EPS
-3.06
-2.02
-0.16
-0.09
-0.07
Diluted EPS
-3.06
-2.02
-0.16
-0.09
-0.07
Basic Average Shares
94,400.0000
94,200.0000
93,700.0000
94,026.8880
94,026.8880
Diluted Average Shares
96,100.0000
95,900.0000
95,000.0000
94,026.8880
94,026.8880
Total Operating Income as Reported
-283,700.0000
-234,300.0000
-800.0000
-12,800.0000
-10,800.0000
Total Expenses
967,900.0000
1,015,200.0000
953,800.0000
891,300.0000
952,900.0000
Net Income from Continuing & Discontinued Operation
-287,300.0000
-189,700.0000
-15,000.0000
-8,100.0000
-6,300.0000
Normalized Income
-8,708.9929
-3,105.0247
5,925.0000
2,410.5000
-4,572.0000
Interest Income
5,200.0000
2,500.0000
8,200.0000
200.0000
1,000.0000
Interest Expense
10,800.0000
10,900.0000
4,200.0000
2,100.0000
1,200.0000
Net Interest Income
-11,800.0000
-8,400.0000
4,000.0000
-1,900.0000
-900.0000
EBIT
-286,100.0000
-231,900.0000
7,300.0000
-12,500.0000
-10,600.0000
EBITDA
12,700.0000
71,000.0000
101,800.0000
63,500.0000
61,600.0000
Reconciled Cost of Revenue
805,800.0000
854,300.0000
804,000.0000
783,700.0000
854,100.0000
Reconciled Depreciation
298,800.0000
302,900.0000
94,500.0000
76,000.0000
72,200.0000
Net Income from Continuing Operation Net Minority Interest
-287,300.0000
-189,700.0000
-15,000.0000
-8,100.0000
-6,300.0000
Total Unusual Items Excluding Goodwill
-287,900.0000
-238,700.0000
-27,900.0000
-14,300.0000
-2,400.0000
Total Unusual Items
-287,900.0000
-238,700.0000
-27,900.0000
-14,300.0000
-2,400.0000
Normalized EBITDA
300,600.0000
309,700.0000
129,700.0000
77,800.0000
64,000.0000
Tax Rate for Calcs
0.0000
0.0002
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
-9,308.9929
-52,105.0247
-6,975.0000
-3,789.5000
-672.0000
12/31/2020 - 5/6/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LUPIN.BO Lupin Limited
2,133.75
-0.77%
 
ZYDUSLIFE.BO Zydus Lifesciences Limited
956.60
-3.26%
 
RDY Dr. Reddy's Laboratories Limited
14.03
-0.88%
 
LNTH Lantheus Holdings, Inc.
97.56
-0.67%
 
ZTS Zoetis Inc.
168.87
+1.14%
 
VTRS Viatris Inc.
11.22
+1.40%
 
TEVA Teva Pharmaceutical Industries Limited
21.85
+0.28%